期刊文献+

多粘菌素B中多粘菌素B_1的制备方法研究 被引量:1

Study on Separation and Purification of Polymyxin B_1 from Polymyxin B
下载PDF
导出
摘要 用反相制备液相色谱从多粘菌素B中分离得到了高纯度多粘菌素B1单体。采用YMC-ODS-A色谱柱,对制备条件进行了优化。最佳制备条件为:流动相组成,含0.1%三氟乙酸的乙腈/水(21/79,V/V);流速为25 mL/min;单针上样量50 mg;收集波长210 nm;收集信号强度:10 mAU;收集液在40℃下旋蒸除去乙腈后冷冻干燥。在该条件下,得到的多粘菌素B1单体纯度为98.76%。 A new RP-HPLC method was established for separation and purification of polymyxin B1 from polymyxin B.Purifiation and analysis were both performed on a YMC-ODS-A column.Experimental parameters were investigated.The optimum separation condition was: mobile phase,acetonitrile-water(21∶79,V/V) containing 0.1% trifluoroacetic acid;flow rate,25 mL/min;sample amount of single,50 mg;collection wavelenth,210 nm;collection signal strength,10 mAU;collection liquid treatment: rotary evaporation at 40℃ and freeze-drying.The purity of the obtained polymyxin B1 product was 98.76%.
出处 《化工时刊》 CAS 2011年第8期20-22,共3页 Chemical Industry Times
基金 上海市科委公共服务平台资助项目(09DZ2292100)
关键词 反相制备液相色谱 多肽类抗生素 多粘菌素B 多粘菌素B1 preparative HPLC polypeptide antibiotics polymyxin B polymyxin B1
  • 相关文献

参考文献6

二级参考文献19

  • 1吕根法,卫国,郭毅斌,肖光夏,郑江,罗高兴.多粘菌素B拮抗内毒素的体外作用研究[J].第三军医大学学报,2004,26(14):1252-1254. 被引量:9
  • 2张樱,陈亚岗,杨青.不动杆菌感染及耐药机制的研究进展[J].国外医学(流行病学.传染病学分册),2005,32(2):109-112. 被引量:93
  • 3张婴元,张敬德,周乐,吴培澄,陈友娣,王宇倩,汪复.头孢哌酮-舒巴坦体外抗菌作用研究[J].中华内科杂志,1995,34(10):676-679. 被引量:52
  • 4石岩,刘大为,许大波,徐英春,陈民均,王辉.泛耐药鲍曼不动杆菌感染临床治疗初探[J].中国感染与化疗杂志,2007,7(1):34-37. 被引量:112
  • 5汪复.多重耐药铜绿假单胞菌与鲍曼不动杆菌严重感染的防治策略[J].中国感染与化疗杂志,2007,7(3):230-232. 被引量:139
  • 6Leek, Kim YA, Joon Y, et al. Increasing prevalance of vancomy cin - resustant enterococci, and cefoxitin, imipenem, and fluoroqrinolone - resistant gram - negative bacili: A KONSAR study in 2002 [ J ]. Yonsei Med J,2004,45:598.
  • 7Zarrilli R, Crispino M, Bagattini M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in anintensive care unit shows the emergence of carbapenem resistance[ J]. J Clin Microbial, 2004, 42(3) :946 -953.
  • 8Raeina R, Estenssoro E, Saenz G, et al. Safe and efficacy of colistin in acinetobacter and pseudomonas infections: a prospective cohort study [J]. Intensive Care Med, 2005, 31 (8) :1058.
  • 9Falagas ME, Kasiakou SK, Tsiodras S, et al. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature[ J ]. Clin Med Res, 2006, 4(2) : 138.
  • 10RAEINA R, ESTENSSORO E, SAENZ G. , et al. Safe ant efficacy of colistin in acinetobacter and pseudomonas infections; a prospective cohort study [ J ]. In tensive Care Med, 2005,31 ( 8 ) : 1058.

共引文献48

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部